Sheets Smith Investment Management Buys New Position in Xometry, Inc. $XMTR

Key Points

• Sheets Smith Investment Management has acquired a new position in Xometry, Inc., purchasing 13,924 shares valued at approximately $347,000 in the first quarter.
• Several other hedge funds have significantly increased their stakes in Xometry, with Federated Hermes Inc. boosting its investment by 264.2% during the same period.
• Wall Street analysts are optimistic about Xometry, with multiple firms recently raising their price targets, resulting in a consensus rating of "Moderate Buy" and a target price of $40.44.

Sheets Smith Investment Management purchased a new position in Xometry, Inc. (NASDAQ:XMTR - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 13,924 shares of the company's stock, valued at approximately $347,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Federated Hermes Inc. boosted its stake in Xometry by 264.2% in the 1st quarter. Federated Hermes Inc. now owns 37,271 shares of the company's stock worth $929,000 after buying an additional 27,036 shares during the last quarter. State of Wyoming increased its stake in Xometry by 8.2% during the fourth quarter. State of Wyoming now owns 8,876 shares of the company's stock worth $379,000 after acquiring an additional 676 shares during the last quarter. Vontobel Holding Ltd. acquired a new stake in Xometry during the first quarter worth about $420,000. GAMMA Investing LLC increased its stake in Xometry by 6,381.9% during the first quarter. GAMMA Investing LLC now owns 25,020 shares of the company's stock worth $623,000 after acquiring an additional 24,634 shares during the last quarter. Finally, SG Americas Securities LLC increased its stake in Xometry by 259.0% during the first quarter. SG Americas Securities LLC now owns 50,035 shares of the company's stock worth $1,247,000 after acquiring an additional 36,097 shares during the last quarter. 97.31% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. The Goldman Sachs Group upped their price target on Xometry from $33.00 to $42.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Cantor Fitzgerald upgraded Xometry from an "underweight" rating to a "neutral" rating and set a $41.00 price target for the company in a research note on Tuesday, August 5th. UBS Group upped their price target on Xometry from $35.00 to $40.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 6th. JPMorgan Chase & Co. upped their price target on Xometry from $36.00 to $38.00 and gave the stock an "overweight" rating in a research note on Tuesday, June 3rd. Finally, Citigroup restated an "outperform" rating on shares of Xometry in a research note on Friday, July 11th. Six research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Xometry has a consensus rating of "Moderate Buy" and a consensus price target of $40.44.

Xometry Trading Up 4.8%

Shares of XMTR opened at $50.63 on Friday. The stock's 50-day moving average is $41.27 and its two-hundred day moving average is $32.78. The stock has a market cap of $2.57 billion, a PE ratio of -41.16 and a beta of 0.87. Xometry, Inc. has a 12 month low of $16.26 and a 12 month high of $51.87. The company has a debt-to-equity ratio of 1.20, a current ratio of 3.91 and a quick ratio of 3.85.

Xometry (NASDAQ:XMTR - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.04. The company had revenue of $162.55 million for the quarter, compared to analysts' expectations of $156.53 million. Xometry had a negative return on equity of 6.79% and a negative net margin of 10.20%.The firm's quarterly revenue was up 22.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.01) earnings per share. Xometry has set its Q3 2025 guidance at EPS. Equities analysts forecast that Xometry, Inc. will post -0.66 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO James Miln sold 598 shares of the firm's stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $50.25, for a total transaction of $30,049.50. Following the completion of the sale, the chief financial officer directly owned 144,115 shares in the company, valued at $7,241,778.75. This trade represents a 0.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Randolph Altschuler sold 9,332 shares of the firm's stock in a transaction dated Wednesday, July 2nd. The shares were sold at an average price of $32.39, for a total value of $302,263.48. Following the sale, the chief executive officer owned 319,602 shares of the company's stock, valued at $10,351,908.78. This represents a 2.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 9.66% of the stock is owned by company insiders.

About Xometry

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.